Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7350744 | 0.84 | CYP3A4 (0.51) | TDP1CYP3A4 | |
| SCHEMBL9015373 | 0.81 | TDP1 (0.48) | TDP1CYP3A4 | |
| SCHEMBL3015198 | 0.81 | TDP1 (0.48) | TDP1CYP3A4 | |
| SCHEMBL19286627 | 0.80 | CYP3A4 (0.57) | TDP1CYP3A4 | |
| SCHEMBL893784 | 0.80 | CYP3A4 (0.57) | TDP1CYP3A4 | |
| SCHEMBL9943757 | 0.79 | CYP3A4 (0.46) | TDP1CYP3A4 | |
| SCHEMBL8610043 | 0.79 | CTSL (0.41) | CYP3A4 | |
| SCHEMBL29961611 | 0.78 | CYP3A4 (0.66) | CYP3A4 | |
| SCHEMBL12249326 | 0.78 | CYP3A4 (0.66) | CYP3A4 | |
| SCHEMBL7021692 | 0.77 | TDP1 (0.48) | TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1751125-B1 | RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND. | CRISTALIA PROD QUIMICOS FARM (BR) | 2010-09-08 | — | — | EP | disclosed |